GlassScriptPhysician profile
Newton William Chism
NPI 1366482507
$1,415.11
in general payments reported to CMS, 2019-2025
19 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $165 · 2021: $343 · 2022: $204 · 2023: $162 · 2024: $178 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.75 | 2019-2025 | Liletta |
| Sumitomo Pharma America, INC. | $144.10 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $119.53 | 2022-2025 | Veozah |
| Mayne Pharma Commercial LLC | $117.10 | 2021-2022 | |
| Pfizer INC. | $99.63 | 2022-2025 | |
| Daiichi Sankyo INC. | $94.09 | 2019-2023 | Injectafer |
| Novo Nordisk INC | $73.60 | 2023-2025 | Wegovy, Saxenda |
| Hologic Sales and Service, LLC | $59.73 | 2023-2024 | Aptima, Novasure, Coolseal Generator |
| Therapeuticsmd, INC. | $55.43 | 2020-2022 | |
| Myovant Sciences INC. | $52.19 | 2021-2022 | |
| Lilly USA, LLC | $47.14 | 2024-2025 | Zepbound |
| Biogen, INC. | $41.42 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $28.15 | 2020-2021 | |
| Allergan, INC. | $21.80 | 2019 | |
| Phathom Pharmaceuticals, INC. | $20.79 | 2024 | Voquezna |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $16.42 | 2023 | Emma and Isa |
| Exeltis, USA INC. | $15.57 | 2025 | Slynd |
| Dysis Medical, INC. | $14.33 | 2020 | |
| Agile Therapeutics, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Newton Chism listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.